1 - 25 of 207
Number of results to display per page
TitleCreatorRelation Is Part Of
1 Anatomy/Morphology of Melanopsin Retinal Ganglion Cells (MRGC) In the Human Retina: Their Number and Connections to the Central Nervous SystemAlfredo A. Sadun; Valerio Carelli; Chiara La Morga; Jens Hannibal; Fred Ross-CisnerosNANOS 2010: Melanopsin Symposium
2 Anatomy/Morphology of Melanopsin Retinal Ganglion Cells (MRGC) In the Human Retina: Their Number and Connections to the Central Nervous System (PowerPoint)Alfredo A. Sadun; Valerio Carelli; Chiara La Morga; Jens Hannibal; Fred Ross-CisnerosNANOS 2010: Melanopsin Symposium
3 The Birmingham Weight loss in Idiopathic Intracranial Hypertension and Intracranial Pressure StudyMichael Burdon; Alexandra Sinclair; Peter Nightingale; Alexandra Ball; Peter Good; Tim Matthews; Andrew Jacks; Mark Lawden; Carl Clarke; Elizabeth Walker; Jeremy Tomlinson; Paul Stewart; Saaeha RauzNANOS 2010: Scientific Platform Presentations
4 The Birmingham Weight loss in Idiopathic Intracranial Hypertension and Intracranial Pressure StudyMichael Burdon; Alexandra Sinclair; Peter Nightingale; Alexandra Ball; Peter Good; Tim Matthews; Andrew Jacks; Mark Lawden; Carl Clarke; Elizabeth Walker; Jeremy Tomlinson; Paul Stewart; Saaeha Rauz NANOS 2010: Scientific Platform Presentations
5 Double-Blind Cross-Over Trial Of Gabapentin And Memantine For Treatment Of Acquired NystagmusM. J. Thurtell; A. C. Joshi; A. C. Leone; R. L. Tomsak; G. S. Kosmorsky; J. S. Stahl; R. J. LeighNANOS 2010: Scientific Platform Presentations
6 Double-Blind Cross-Over Trial Of Gabapentin And Memantine For Treatment Of Acquired NystagmusMatthew Thurtell; Anand Joshi; Alice Leone; Robert Tomsak; Gregory Kosmorsky; John Stahl; John LeighNANOS 2010: Scientific Platform Presentations
7 Firing and Receptive Field Properties of Melanopsin Retinal Ganglion CellsAki KawasakiNANOS 2010: Melanopsin Symposium
8 Firing and Receptive Field Properties of Melanopsin Retinal Ganglion Cells (PowerPoint)Aki KawasakiNANOS 2010: Melanopsin Symposium
9 Hereditary Optic Neuropathy, Is There A Treatment?Nancy J. Newman; Alfredo SadunNANOS 2010: Controversies in Neuroophthalmology
10 Low-Contrast Letter Acuity Detects Visual Function Improvement in Phase 3 Relapsing MS Trials of NatalizumabLaura J. Balcer; Steven L. Galetta; Chris Polman; Richard Rudick; Frederick Munschauer; Peter Calabresi; Eric R. Eggenberger; Annie Zhang; Richard KimNANOS 2010: Scientific Platform Presentations
11 Low-Contrast Letter Acuity Detects Visual Function Improvement in Phase 3 Relapsing MS Trials of NatalizumabLaura J. Balcer; Steven L. Galetta; Chris Polman; Richard Rudick; Frederick Munschauer; Peter Calabresi; Eric R. Eggenberger; Annie Zhang; Richard KimNANOS 2010: Scientific Platform Presentations
12 Melanopsin Photopigment, Light Phototransduction Pathway, and Pigment RegenerationKenneth S. ShindlerNANOS 2010: Melanopsin Symposium
13 Melanopsin Photopigment, Light Phototransduction Pathway, and Pigment Regeneration (PowerPoint)Kenneth S. ShindlerNANOS 2010: Melanopsin Symposium
14 Melanopsin Retinal Ganglion Cells and CNS FunctionIvy Dreizin, MDNANOS 2010: Melanopsin Symposium
15 Melanopsin Retinal Ganglion Cells and CNS Function (PowerPoint)Ivy Dreizin, MDNANOS 2010: Melanopsin Symposium
16 Melanopsin Retinal Ganglion Cells and Pupil Function in Retinal and Optic Nerve DisordersRandy H. KardonNANOS 2010: Melanopsin Symposium
17 Melanopsin Retinal Ganglion Cells and Pupil Function in Retinal and Optic Nerve Disorders (PowerPoint)Randy H. Kardon; Aki Kawasaki; Susan Anderson; Don Hood; Edwin StoneNANOS 2010: Melanopsin Symposium
18 Neurofibromatosis Type 1 Associated Optic Glioma Visual Outcomes Following Chemotherapy: A Multi-center Retrospective AnalysisMichael J. Fisher; Laura Balcer; Robert Listernick; David Gutmann; Roger Packer; Rosalie Ferner; Robert Hoffman; Uri Tabori; Eric Bouffet; Darren Hargrave; Joel Charrow; Janice Lasky Zeid; Anne Albers; Annie Kuo; Michael Loguidice; Angie Miller; Grant LiuNANOS 2010: Scientific Platform Presentations
19 Neurofibromatosis Type 1 Associated Optic Glioma Visual Outcomes Following Chemotherapy: A Multi-center Retrospective AnalysisMichael J. Fisher; Laura Balcer; Robert Listernick; David Gutmann; Roger Packer; Rosalie Ferner; Robert Hoffman; Uri Tabori; Eric Bouffet; Darren Hargrave; Joel Charrow; Janice Lasky Zeid; Anne Albers; Annie Kuo; Michael Loguidice; Angie Miller; Grant LiuNANOS 2010: Scientific Platform Presentations
20 Neuromyelitis Optica, Is It a Distinct Entity from MS and What Are the Treatment Implications?Jeffrey L. Bennett, MD, PhD; Steven Galetta, MDNANOS 2010: Controversies in Neuroophthalmology
21 Neuronal Protection of the Retinal Ganglion CellRaymond Magauran; Shalesh Kaushal; Syed Noorwez; Amit Roy; Kamolika Roy; Ranjith Reddy; George PetersNANOS 2010: Scientific Platform Presentations
22 Neuronal Protection of the Retinal Ganglion CellRaymond Magauran; Reddy Ranjith Kumar Sama; Shalesh KaushalNANOS 2010: Scientific Platform Presentations
23 Photophobia and the Melanopsin Retinal Ganglion Cell: a Connection?Kathleen B. Digre, MDNANOS 2010: Melanopsin Symposium
24 Photophobia and the Melanopsin Retinal Ganglion Cell: a Connection? (PowerPoint)Kathleen B. Digre, MDNANOS 2010: Melanopsin Symposium
25 Pupil Disorders, Is Pharmacological Testing Necessary?Randy H. Kardon; Jonathan D. TrobeNANOS 2010: Controversies in Neuroophthalmology
1 - 25 of 207